EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Tissue‐resident innate lymphoid cells in asthma

Xiaoxu Wang, Yue Kong, Bingqing Zheng, Xiaomin Zhao, Mingzhe Zhao, Bin Wang, Chang Liu, Peizheng Yan iD

The Journal of Physiology · 2023-09 · 601 (18) · 3995-4012

DOI: 10.1113/jp284686 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, published online on 2023-07-24. Written by Xiaoxu Wang and 7 co-authors. Institution: The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Major MEDLINE topics: Asthma, Immunity, Innate. Cited 9 times so far (Crossref); 145 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Asthma is a chronic airway inflammatory disease whose global incidence increases annually. The role of innate lymphoid cells (ILCs) is a crucial aspect of asthma research with respect to different endotypes of asthma. Based on its pathological and inflammatory features, asthma is divided into type 2 high and type 2 low endotypes. Type‐2 high asthma is distinguished by the activation of type 2 immune cells, including T helper 2 (Th2) cells and ILC2s; the production of cytokines interleukin (IL)‐4, IL‐5 and IL‐13; eosinophilic aggregation; and bronchial hyper‐responsiveness. Type‐2 low asthma represents a variety of endotypes other than type 2 high endotype such as the IL‐1β/ILC3/neutrophil endotype and a paucigranulocytic asthma, which may be insensitive to corticosteroid treatment and/or associated with obesity. The complexity of asthma is due to the involvement of multiple cell types, including tissue‐resident ILCs and other innate immune cells including bronchial epithelial cells, dendritic cells, macrophages and eosinophils, which provide immediate defence against viruses, pathogens and allergens. On this basis, innate immune cells and adaptive immune cells combine to induce the pathological condition of asthma. In addition, the plasticity of ILCs increases the heterogeneity of asthma. This review focuses on the phenotypes of tissue‐resident ILCs and their roles in the different endotypes of asthma, as well as the mechanisms of tissue‐resident ILCs and other immune cells. Based on the phenotypes, roles and mechanisms of immune cells, the therapeutic strategies for asthma are reviewed. image

Subjects

MeSH terms (MEDLINE)

AsthmaImmunity, InnatePulmonary Disease, Chronic ObstructiveHumansLymphocytesCytokines

Author keywords

asthmacytokinesinnate immune cellsmechanismstissue-resident innate lymphoid cells

Substances

Cytokines

Authors and institutions

  • The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of traditional Chinese medicine, Shandong Traditional Chinese Medicine College, YanTai, China.

ORCID profiles: Peizheng Yan

Cite

APA

Wang, X., Kong, Y., Zheng, B., Zhao, X., Zhao, M., Wang, B., Liu, C., & Yan, P. (2023). Tissue‐resident innate lymphoid cells in asthma. The Journal of Physiology, 601(18), 3995-4012. https://doi.org/10.1113/jp284686

Vancouver

Wang X, Kong Y, Zheng B, Zhao X, Zhao M, Wang B, et al. Tissue‐resident innate lymphoid cells in asthma. The Journal of Physiology. 2023;601(18):3995-4012. doi:10.1113/jp284686

BibTeX
@article{Wang2023,
  author = {Wang, Xiaoxu and Kong, Yue and Zheng, Bingqing and Zhao, Xiaomin and Zhao, Mingzhe and Wang, Bin and Liu, Chang and Yan, Peizheng},
  title = {Tissue‐resident innate lymphoid cells in asthma},
  journal = {The Journal of Physiology},
  year = {2023},
  volume = {601},
  number = {18},
  pages = {3995--4012},
  doi = {10.1113/jp284686}
}
Start for free →